The antiepileptic drug carbamazepine produces dose related anticonvuls
ant effects in genetically epilepsy-prone rats (GEPRs) and most other
animal seizure models. Carbamazepine releases serotonin as part of the
pharmacodynamic action by which it suppresses convulsions in GEPRs an
d it releases serotonin in non-epileptic Sprague-Dawley rats. The two
strains which make up the GEPR seizure model (moderate seizure GEPR-3s
and severe seizure GEPR-9s) experience anticonvulsant effects in resp
onse to different doses of carbamazepine (GEPR-3 ED50=25 mg/kg; GEPR-9
ED50=3 mg/kg). The present study determined that carbamazepine produc
es a dose related increase in extracellular serotonin in each of the t
wo GEPR strains. The doses of carbamazepine required to increase extra
cellular serotonin are similar to the doses required for an anticonvul
sant effect in each of the strains. This result provides further suppo
rt for the hypothesis that release of serotonin by carbamazepine is an
important part of the pharmacodynamic action by which this drug suppr
esses seizures. (C) 1997 Elsevier Science Ireland Ltd.